Fließer-Görzer [Ordination]
Saint Stefan 8511
1 studies enrolling now · 8 studies all time
What they study most
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Heart Failure, Heart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2, Non-alcoholic Steatohepatitis, Obesity, Overweight, Type 2 Diabetes, Type 2 Diabetes Mellitus
Studies at this site
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight — Recruiting now
- Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) — Running, not enrolling
- A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
- A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight — Completed
- A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes — Completed
- A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity — Completed
- A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6) — Completed
- Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes — Completed